ADMA BIOLOGICS INC - COMMON STOCK

ADMA Biologics Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress and Accomplishments

12 May 2021 15:05:02 By Nasdaq GlobeNewswire

ADMA Biologics to Report First Quarter 2021 Financial Results on May 12, 2021

05 May 2021 06:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Receives FDA Approval for Increased IVIG Production Scale

28 Apr 2021 06:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Opens Newest ADMA BioCenters Plasma Collection Facility in Goose Creek, S.C.

26 Apr 2021 07:00:02 By Nasdaq GlobeNewswire

ADMA Biologics Announces Poster Presentation Highlighting Pharmacoeconomic Burden of HIV and HBV Infection in Sexual Assault Patients at the 2021 Academy of Managed Care Pharmacy Virtual Annual Meeting

13 Apr 2021 07:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Reports Fourth Quarter and Full Year 2020 Financial Results

25 Mar 2021 15:05:01 By Nasdaq GlobeNewswire

ADMA Biologics to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021

18 Mar 2021 07:00:00 By Nasdaq GlobeNewswire

ADMA Biologics to Participate in the Jefferies Virtual Plasma Summit

04 Mar 2021 07:00:02 By Nasdaq GlobeNewswire

ADMA Biologics Expands Global Regulatory Approval Presence and Announces FDA Approval to Commence Hepatitis B Plasma Collections

03 Mar 2021 07:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Presents Late-Breaking Poster Presentation Highlighting Clinical Utility of S. Pneumoniae Hyperimmune Globulin at the 2021 American Academy of Allergy, Asthma & Immunology Virtual Annual Meeting

26 Feb 2021 07:00:00 By Nasdaq GlobeNewswire